$6.85
-4.2%Innventure, Inc. operates companies with a focus on transformative, sustainable technology solutions acquired or licensed from multinational corporations. The company was founded in 2015 and is based in Orlando, Florida.
Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.
Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.
Positive working capital, but relatively tight. The company should monitor cash flow carefully.
Capital-intensive business with significant long-term investments in property, equipment, or intangibles.
Conservative with tight liquidity: Low debt is positive, but current ratio warrants attention. Consider whether the company is efficiently deploying its equity capital.
INV • NASDAQ
| Innventure, Inc. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
ASSETS | |||||
CURRENT ASSETS | |||||
60.4M | 11.1M | 2.6M | 7.5M | 237.4K | |
60.4M | 11.1M | 2.6M | 7.5M | 237.4K | |
1.1M | 283K | 0.0 | 0.0 | 0.0 | |
1.1M | 283K | 0.0 | 0.0 | 0.0 | |
1.6M | 5.2M | 0.0 | 0.0 | 0.0 | |
0.0 | 3.2M | 487K | 257K | 707.7K | |
20M | 4.5M | 2.6M | 14K | 0.0 | |
83.2M | 24.3M | 5.7M | 7.8M | 945.1K | |
NON-CURRENT ASSETS | |||||
1.9M | 1.4M | 637K | 0.0 | 0.0 | |
323.5M | 667.9M | 0.0 | 0.0 | 0.0 | |
160.5M | 182.2M | 0.0 | 0.0 | 0.0 | |
484M | 850.1M | 0.0 | 0.0 | 0.0 | |
28.7M | 28.7M | 14.2M | 19.8M | 232.3M | |
1.4M | 766K | 1.1M | 339K | 566.2K | |
516M | 881M | 15.9M | 20.2M | 232.9M | |
599.2M | 905.3M | 21.6M | 28M | 233.8M | |
LIABILITIES | |||||
CURRENT LIABILITIES | |||||
3.3M | 3.2M | 93K | 84K | 0.0 | |
2.6M | 3.2M | 93K | 84K | 0.0 | |
723K | 0.0 | 0.0 | 0.0 | 0.0 | |
0.0 | 11.8M | 4.8M | 892K | 0.0 | |
25.1M | 14.6M | 1.9M | 2.5M | 0.0 | |
23K | 0.0 | 0.0 | 0.0 | 0.0 | |
47.9M | 39.7M | 1.4M | 896K | 470.4K | |
76.3M | 69.3M | 8.2M | 4.3M | 470.4K | |
NON-CURRENT LIABILITIES | |||||
8.3M | 13.7M | 5.5M | 3.4M | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 9.8M | |
13.8M | 0.0 | 0.0 | 0.0 | 0.0 | |
17.1M | 56M | 26.4M | 31.4M | 9.5M | |
39.2M | 69.6M | 31.9M | 34.9M | 19.3M | |
115.5M | 139M | 40.1M | 39.2M | 19.8M | |
SHAREHOLDERS' EQUITY | |||||
0.0 | 0.0 | 41.4M | 24.1M | 0.0 | |
7K | 4K | 2.8M | 2.6M | 232.3M | |
0.0 | 502.9M | 0.0 | 0.0 | 0.0 | |
-371.6M | -78.3M | -64.3M | -38.6M | -18.3M | |
-1.3M | 909K | 0.0 | 0.0 | 0.0 | |
577.1M | 1.0 | 0.0 | 0.0 | 0.0 | |
204.2M | 425.5M | -20M | -11.8M | 214M | |
483.7M | 766.3M | -18.5M | -11.2M | 214M | |
279.5M | 340.8M | 1.6M | 656K | 0.0 | |
SUMMARY | |||||
599.2M | 905.3M | 21.6M | 28M | 233.8M | |
28.7M | 28.7M | 14.2M | 19.8M | 232.3M | |
33.4M | 28.3M | 7.4M | 5.9M | 0.0 | |
-27.1M | 17.2M | 4.8M | -1.6M | -237.4K | |
54,555,555 | 54,555,555 | 54,555,555 | 54,555,555 | 54,555,555 |
INV - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 20, 2026 | May 15, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 14, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 14, 2026 | May 14, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 29, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 30, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 27, 2026 | April 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 21, 2026 | April 20, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 15, 2026 | April 14, 2026 | 2026 | |
S-3/A S-3/A (Amended) N/A | April 01, 2026 | April 01, 2026 | ||
10-K 10-K 2025 FY FY | March 30, 2026 | December 31, 2025 | 2025 |
Continue your INV research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.